]>
IRCT2016070726023N1 IRCT 2016-10-13 Vice chancellor for research of Mashhad University of Medical Sciences Patency comparison between two different kind of vascular accesses in hemodialysis patients. Comparison of vascular patency in basilic vein transposition compared to straight 6-mm grafts, as upper arm vascular access, in hemodialysis patients. 2016-07-10 anticipated 60 Complete https://irct.ir/trial/21682 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Random numbers table was used for the randomization in this study. 3 Chronic Renal Failure. Intervention 1: Intervention group 1: in order to creating dialysis vascular access, surgical operation will be done to perform basilic vein transposition. In this group after explore and superficialisation of the basilic vein, vascular anastomosis will be done with brachial artery. Intervention 2: Intervention group 2: Surgical operation for creating brachioaxillary prosthetic 6 mm graft between axillary vein and brachial artery. In this group after axillary vein and brachial artery exploration the graft passed from the anterior of arm and vascular anastomosis will be done for graft embedding.
public Dr Pouya Tayebi
Imam Reza Hospital, Vascular Surgery Department
Mashhad Iran (Islamic Republic of) +98 51 3841 2088 tayebip941@mums.ac.ir Mashhad University of Medical Sciences scientific Dr Pouya Tayebi
Imam Reza Hospital, Vascular Surgery Department
Mashhad Iran (Islamic Republic of) 00985138412088 +98 51 3841 2088 tayebip941@yahoo.com Mashhad University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Inclusion criteria: Patients Suffering end stage renal diseases with no possibility of creating the radiocephalic or brachiocephalic arteriovenous fistula for hemodialysis or they already have fistula but it has been damaged and unusable; No previous Basilic vein transposition or arteriovenous graft in the site of operation; No history of current medication with anticoagulants or antiplatelet agents; Age 30-80 years old. Exclusion criteria: Anticoagulant or antiplatelet treatment after surgery and during follows up; cease hemodialysis from the created access after the operation for any reason. 30 years 80 years Both N18.5 Chronic kidney disease, stage 5 Treatment - Surgery Treatment - Surgery Intervention group 1: in order to creating dialysis vascular access, surgical operation will be done to perform basilic vein transposition. In this group after explore and superficialisation of the basilic vein, vascular anastomosis will be done with brachial artery. Intervention group 2: Surgical operation for creating brachioaxillary prosthetic 6 mm graft between axillary vein and brachial artery. In this group after axillary vein and brachial artery exploration the graft passed from the anterior of arm and vascular anastomosis will be done for graft embedding. Access patency time. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery up to one year. Method of measurement: Observation for finding the evidence of created access obstruction or successful dialysis. Presence of a palpable thrill in created access. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery up to one year. Method of measurement: Dialysis Access physical examination for thrill strength and consistency. Vice chancellor for research of Mashhad University of Medical Sciences Approved 2016-08-17 Ethics committee of Mashhad University of Medical sciences Mashhad University of Medical sciences, Daneshgah street Mashhad Iran (Islamic Republic of)